ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Baltimore, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Overweight
Foot Ulcer

Diabetes trials near Baltimore, MD, USA:

Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers (GD-T2D)

Use Dapagliflozin 10 mg, Saxagliptin 5 mg, Metformin 500 mg treat type 2 diabetes patients with controlled cancers...

Active, not recruiting
Type 2 Diabetes
Drug: Farxiga® (dapagliflozin) + Onglyza® (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes
Drug: China Import (dapagliflozin) + China Import (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes

Phase 2, Phase 3

Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair

Rockville, Maryland, United States

The study is a prospective, randomized, 52-week double-blind, placebo-controlled, multicenter trial in subjects with T1D followed by a 2-year safety...

Active, not recruiting
Diabetes Mellitus, Type 1
Other: TOL-3021 Placebo
Biological: TOL-3021

Phase 2

Tolerion

Baltimore, Maryland, United States and 22 other locations

This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...

Enrolling
Diabetes
Type2diabetes
Device: ReCET Treatment
Device: Sham Procedure
Endogenex

Baltimore, Maryland, United States and 44 other locations

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Baltimore, Maryland, United States and 24 other locations

This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good...

Enrolling
Type II Diabetes Mellitus
Other: Placebo
Drug: CX11

Phase 2

Corxel Pharmaceuticals

Silver Spring, Maryland, United States and 45 other locations

The primary objective of this study is to demonstrate that KAI-9531 subcutaneous (SC) injection once weekly is superior to placebo on:* Percent chang...

Enrolling
Overweight With Diabetes
Obesity With Diabetes
Drug: KAI-9531
Drug: Placebo

Phase 3

Kailera

Columbia, Maryland, United States and 36 other locations

The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT/ rilparencel)
Procedure: Sham Comparator

Phase 3

Prokidney

Takoma Park, Maryland, United States and 96 other locations

with type 2 diabetes (T2D)....

Enrolling
Type 2 Diabetes
Other: Facilitated referral to a cardiometabolic team-based center
Other: Decision support
American College of Cardiology

Washington, District of Columbia, United States

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd also known as retogatein compared...

Active, not recruiting
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Baltimore, Maryland, United States and 59 other locations

bring the blood glucose level back to normal.A high blood sugar level is known as diabetes. The most common form of diabetes, type...

Enrolling
Type 2 Diabetes
Drug: HP-211
Drug: Placebo

Phase 2

Housey Healthcare

Burke, Virginia, United States of America and 24 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems